ArticleJournal of translational medicine2024

Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.

Huan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.